Company intelligence / Profile preview

Trias Pharma

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Trias Pharma specializes in the hands-on, expert development of robust solid oral dosage forms—including tablets and soft capsules—for pharmaceutical companies worldwide. The team has contributed to the successful development of over 70 products, with deep experience in formulation, analysis, manufacturing, biopharmaceuticals, regulatory affairs, and commercial/contractual aspects. They also have recognized expertise in medicinal cannabis formulations.

Modalities: Small moleculeBiologic (for oral, pulmonary, and local delivery systems)
Industry: Contract Manufacturing Organization

Partnerships

Not specified publicly. Likely works with various pharma/biotech clients under confidentiality agreements typical for CDMOs/consultancies.

Beyond the preview

Go deeper on Trias Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trias Pharma.

Explore the full profile